Clinical Trial Update: Clinical Randomisation of an Antifibrinolytic in Significant Head Injury [Phase 3]

View source ↗

Summary

Phase 3 randomized trial update evaluating an antifibrinolytic in significant head injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Traumatic Brain Injury | Phase 3 | Status: COMPLETED